Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vigamox vs Cravit for wound healing after cataract surgery
NCT00840580Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Jan 2009
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Moxisurge in Bacterial ocular infection, sponsored by Alcon Inc.. Started Jan 2009; status: completed.
02
Drugs
Moxisurge
03
Conditions
Bacterial ocular infection
Beyond the preview
Go deeper on NCT00840580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00840580.